STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABSI
  4. [Form 4] Absci Corp Insider Trading Activity

Absci (NASDAQ: ABSI) awards director 10,100 RSUs and 39,800 options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Absci Corp director Daniel A. Rabinovitsj received new equity awards in the form of restricted stock units and stock options. He was granted 10,100 RSUs, each representing the right to receive one share of common stock. After this grant, he directly holds 33,420 common shares.

He was also granted options on 39,800 shares of common stock at an exercise price of $7.34 per share, expiring in 2036. Both the RSUs and options vest in full on the earlier of the first anniversary of the grant date or Absci’s next annual stockholder meeting, as long as he continues serving the company.

Positive

  • None.

Negative

  • None.
Insider Rabinovitsj Daniel A
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 39,800 $0.00 --
Grant/Award Common Stock 10,100 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 39,800 shares (Direct, null); Common Stock — 33,420 shares (Direct, null)
Footnotes (1)
  1. The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.
RSUs granted 10,100 shares Restricted Stock Units granted to director on June 4, 2026
Common shares held after grant 33,420 shares Director’s direct common stock holdings following RSU award
Options granted 39,800 options Stock options on common stock granted on June 4, 2026
Option exercise price $7.34 per share Exercise price for 39,800 stock options
Option expiration June 3, 2036 Expiration date of the granted stock options
Restricted Stock Units ("RSUs") financial
"The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)" with an exercise price of 7.3400."
2021 Stock Option and Incentive Plan financial
"RSUs issued under the Absci Corporation 2021 Stock Option and Incentive Plan."
exercise price financial
"conversion_or_exercise_price: "7.3400" for the stock option grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rabinovitsj Daniel A
(Last)(First)(Middle)
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BOULEVARD
(Street)
VANCOUVER WASHINGTON 98683
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026A10,100(1)A$033,420D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$7.3406/04/2026A39,800 (2)06/03/2036Common Stock39,800$039,800D
Explanation of Responses:
1. The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.
2. The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.
Remarks:
/s/ Shelby Walker, attorney-in-fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Absci (ABSI) director Daniel Rabinovitsj report?

Absci director Daniel A. Rabinovitsj reported receiving equity compensation, including 10,100 restricted stock units and stock options on 39,800 shares. These awards increase his potential ownership stake and are tied to continued service through a future vesting date.

How many Absci (ABSI) shares does Daniel Rabinovitsj hold after this grant?

After the grant, Daniel A. Rabinovitsj holds 33,420 shares of Absci common stock directly. This figure reflects his non-derivative holdings following the 10,100-share RSU award, separate from the 39,800 shares underlying his new stock options.

What are the details of Daniel Rabinovitsj’s new Absci stock options?

Rabinovitsj received stock options covering 39,800 Absci common shares with a $7.34 exercise price. The options vest in full on the earlier of the first anniversary of the grant date or Absci’s next annual stockholder meeting, and expire in 2036.

How do the new Absci RSUs granted to Daniel Rabinovitsj vest?

The 10,100 RSUs vest and settle in full on the earlier of the first anniversary of the grant date or Absci’s next annual meeting. Vesting requires Daniel A. Rabinovitsj to remain in continuous service with Absci through that vesting date.

Was Daniel Rabinovitsj’s Absci Form 4 transaction an open-market stock purchase?

No, the transactions reflect equity compensation awards, not open-market purchases. Rabinovitsj received 10,100 RSUs and options on 39,800 shares as grants, both at a reported price of $0.00 per share, consistent with standard director compensation structures.